Biopharma Excellence by PharmaLex

EUIPO EUIPO 2021 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark Biopharma Excellence by PharmaLex was filed as Word mark on 04/16/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/31/2021. The current status of the mark is "Trademark registered".

Trademark Details Last update: May 22, 2025

Trademark form Word mark
File reference 018454268
Application date April 16, 2021
Publication date May 25, 2021
Entry date August 31, 2021
Expiration date April 16, 2031

Trademark owner

Basler Strasse 7
61352 Bad Homburg
DE

Trademark representatives

7 Rue Guimard 1040 Brussels BE

goods and services

9 Software; automation software; artificial intelligence apparatus; information technology apparatus; computers; computer programs for data processing; computer software applications, downloadable; unified communications software; assistive software
35 advertising, management for others, business administration; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; support and advice in the context of drug distribution in retail and wholesale; providing outsourced office functions services for drug approval, manufacturing, distribution, security and monitoring; assistance and consultancy in the context of the retailing and wholesaling of medicines; consultancy services in the fields of controlling and managing information and implementing and managing databases
42 scientific and technological services and research and design relating thereto; scientific, technological, medical and pharmaceutical research and development services; industrial analysis and research services; research and development of new products for others; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services; biological research; clinical research; providing medical and scientific research information; provision of surveys [scientific]; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars, therapeutics; development of a web application for entering and evaluating informative texts for pharmaceuticals and medical products, in particular instructions for use, package inserts, specialist information and for the provision of various documents; database services, namely storage of data in computer databases; conversion of data or documents from physical to electronic media; testing, inspection or research of pharmaceuticals and medicines; design, engineering, research, development and testing services; research in the field of gene therapy; quality assurance, quality control and quality management consultancy; research services relating to scientific work; preparation of scientific analyzes and evaluations; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; medical laboratory services; information technology services for the pharmaceutical and healthcare industries; scientific evaluation of drug efficacy; services for assessing the efficiency of pharmaceuticals; analysis and evaluation of product design; analysis and evaluation of product development; quality control testing; materials testing and evaluation; product safety testing; certification [quality control]; quality testing of products for certification purposes; support and advice on drug safety and monitoring; consultancy services for the development and approval process of biological samples or chemical samples for therapeutic and diagnostic purpose; consultancy services in the field of design, planning, implementation and project management of clinical trials, pharmacovigilance, pharmaceutical and biotechnology product development; consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and pharmacogenetics; laboratory analysis service relating to the diagnosis and treatment of persons
44 Medical and veterinary services; pharmacy advice; providing information relating to the preparation and dispensing of medications; provision of pharmaceutical information; provision of information relating to medicine; consultancy and information services provided via the Internet relating to pharmaceutical products; consultancy and information services relating to pharmaceutical products; consultancy and information services relating to biopharmaceutical products; advisory services relating to pharmaceuticals; medical, diagnostic and pharmaceutical services and advice; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; medical analysis and examinations; medical treatment services; medical services; medical screening; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of illnesses; medical, diagnostic and pharmaceutical services and advice in the field of drug safety; providing information in the field of pharmacovigilance and adverse event reporting
45 regulatory compliance auditing; regulatory compliance consulting services; regulatory support and advice in the context of drug approval; submission of documents, reports and records required for drug approval by regulatory authorities (Regulatory compliance auditing); consultancy services in the fields of regulatory compliance and oversight; advisory services relating to regulatory affairs; regulatory maintenance of marketing authorizations following approval

Trademark history

Date Document number Area Entry
May 21, 2025 Transfer / Change of address, Published
January 10, 2025 Change Representative, Published
October 25, 2024 RAW: Representative - Deletion of the representative, Published
October 18, 2022 Change Representative, Published

ID: 11018454268